Sequent Scientific, Viyash Life Sciences explore merger worth Rs 7000-8000 cr
Sequent Scientific and Viyash Life Sciences are in talks for a potential merger worth Rs. 7000-8000 crore, according to people familiar with the matter.
The former is listed and the latter unlisted.
The two companies boards are likely to hold independent meetings to discuss the possibility of a deal in the coming weeks, according to the sources. There is no certainty a transaction will materialize, they said.
Global private equity firm Carlyle is a shareholder in both companies.
Viyash Life Sciences generated 1.5 x the operating profits of Sequent Scientific in financial year 2023-24, as per the sources.
Artificial Intelligence(AI)
Java Programming with ChatGPT: Learn using Generative AI
By — Metla Sudha Sekhar, Developer and Lead Instructor
Artificial Intelligence(AI)
Basics of Generative AI: Unveiling Tomorrow's Innovations
By — Metla Sudha Sekhar, Developer and Lead Instructor
Artificial Intelligence(AI)
Generative AI for Dynamic Java Web Applications with ChatGPT
By — Metla Sudha Sekhar, Developer and Lead Instructor
Artificial Intelligence(AI)
Mastering C++ Fundamentals with Generative AI: A Hands-On
By — Metla Sudha Sekhar, Developer and Lead Instructor
Artificial Intelligence(AI)
Master in Python Language Quickly Using the ChatGPT Open AI
By — Metla Sudha Sekhar, Developer and Lead Instructor
Office Productivity
Zero to Hero in Microsoft Excel: Complete Excel guide 2024
By — Metla Sudha Sekhar, Developer and Lead Instructor
Astrology
Vastu Shastra Course
By — Sachenkumar Rai, Vastu Shashtri
Data Science
SQL for Data
